methyl 5-aminolevulinate has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, W; Li, K; Lin, J; Liu, Q; Lv, G; Peng, Y; Qiu, L; Xie, M | 1 |
| Cinelli, E; Donnarumma, M; Fabbrocini, G; Panariello, L | 1 |
2 other study(ies) available for methyl 5-aminolevulinate and Benign Neoplasms
| Article | Year |
|---|---|
A new GSH-responsive prodrug of 5-aminolevulinic acid for photodiagnosis and photodynamic therapy of tumors.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Glutathione; Humans; Levulinic Acids; Neoplasms; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Prodrugs; Protoporphyrins | 2019 |
Case series showing the efficacy of 5-aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor-induced paronychia and pyogenic granuloma-like lesions.
Topics: Administration, Topical; Afatinib; Aged; Aminolevulinic Acid; ErbB Receptors; Female; Follow-Up Studies; Granuloma, Pyogenic; Humans; Male; Middle Aged; Neoplasms; Paronychia; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Protein Kinase Inhibitors; Treatment Outcome | 2019 |